{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T21:30:03Z","timestamp":1793568603790,"version":"4.5.0"},"reference-count":34,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>We investigated the development of giant cell arteritis (GCA) in patients with prior diagnoses of isolated polymyalgia rheumatica and\/or peripheral arthritis (PMR\/PA), and the potentially relevant characteristics of both illnesses in such patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We retrospectively compared the features of 67 patients at the onset of PMR\/PA, and their outcomes, to those of a random group of 65 patients with PMR\/PA who did not develop late GCA. We also compared the features and outcomes of patients with late GCA to those of a random sample of patients with more usual GCA (65 with concurrent PMR\/PA and 65 without).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Patients with late GCA represented 7.4% of all patients with GCA included in a large hospital-based inception cohort. PMR\/PA preceded overt GCA by 27 months on average. Permanent visual loss developed in 10 patients, including 8 of 48 (17%) patients featuring cranial arteritis. A questionable female predominance was the only distinguishing feature of PMR\/PA evolving into GCA; late GCA more often featured subclinical aortitis (OR 6.42, 95% CI 2.39\u201317.23; p &lt; 0.001), headache (OR 0.44, 95% CI 0.19\u20131.03; p = 0.06), and fever (OR 0.29, 95% CI 0.13\u20130.64; p = 0.002) less often compared to the more usual form of GCA. Patients with either form of GCA experienced similar outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>A cranial arteritis pattern of late GCA is associated with a significant risk for ischemic blindness. However, compared to the usual form of GCA, late GCA is often less typical, with a higher frequency of silent aortitis. Patients with relapsing\/refractory PMR may not be at increased risk for late GCA.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.170455","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T11:35:16Z","timestamp":1521113716000},"page":"678-685","source":"Crossref","is-referenced-by-count":21,"title":["Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study"],"prefix":"10.3899","volume":"45","author":[{"given":"Eric","family":"Liozon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"de Boysson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Dalmay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Gondran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holy","family":"Bezanahary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Fauchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Heang","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"2018112909383036000_45.5.678.1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X13512450"},{"key":"2018112909383036000_45.5.678.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.09.007"},{"key":"2018112909383036000_45.5.678.3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0950-3579(05)80059-7","article-title":"Relation of giant cell arteritis to polymyalgia rheumatica","volume":"5","author":"Healey","year":"1991","journal-title":"Baillieres Clin Rheumatol"},{"key":"2018112909383036000_45.5.678.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2003.09.008"},{"key":"2018112909383036000_45.5.678.5","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatic: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology"},{"key":"2018112909383036000_45.5.678.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-319X(02)00007-6"},{"key":"2018112909383036000_45.5.678.7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.8.662"},{"key":"2018112909383036000_45.5.678.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel376"},{"key":"2018112909383036000_45.5.678.9","first-page":"1043","article-title":"Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation","volume":"32","author":"Pease","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909383036000_45.5.678.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep395"},{"key":"2018112909383036000_45.5.678.11","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.11.1021"},{"key":"2018112909383036000_45.5.678.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00117-4"},{"key":"2018112909383036000_45.5.678.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.4.367"},{"key":"2018112909383036000_45.5.678.14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318145275c"},{"key":"2018112909383036000_45.5.678.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.06.009"},{"issue":"4 Suppl 20","key":"2018112909383036000_45.5.678.16","first-page":"S51","article-title":"Distal musculoskeletal manifestations in polymyalgia rheumatica","volume":"18","author":"Salvarani","year":"2000","journal-title":"Clin Exp Rheumatol Suppl"},{"key":"2018112909383036000_45.5.678.17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.11.1060"},{"key":"2018112909383036000_45.5.678.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330810"},{"key":"2018112909383036000_45.5.678.19","doi-asserted-by":"crossref","first-page":"e3851","DOI":"10.1097\/MD.0000000000003851","article-title":"18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: a multicenter cohort of 130 patients","volume":"95","author":"de Boysson","year":"2016","journal-title":"Medicine"},{"key":"2018112909383036000_45.5.678.20","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780330804","article-title":"Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis","volume":"33","author":"Lie","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2018112909383036000_45.5.678.21","doi-asserted-by":"publisher","DOI":"10.1002\/art.23700"},{"key":"2018112909383036000_45.5.678.22","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151135"},{"key":"2018112909383036000_45.5.678.23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133850"},{"key":"2018112909383036000_45.5.678.24","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1007\/s00259-017-3774-5","article-title":"Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET\/CT in detection of large-vessel involvement","volume":"44","author":"De Boysson","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2018112909383036000_45.5.678.25","doi-asserted-by":"crossref","first-page":"e4974","DOI":"10.1097\/MD.0000000000004974","article-title":"Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients","volume":"95","author":"Ly","year":"2016","journal-title":"Medicine"},{"key":"2018112909383036000_45.5.678.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.12.023"},{"issue":"1 Suppl 52","key":"2018112909383036000_45.5.678.27","first-page":"S25","article-title":"Polymyalgia rheumatica can recur years after discontinuation of corticosteroid therapy","volume":"27","author":"Docken","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909383036000_45.5.678.28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-77-6-845"},{"key":"2018112909383036000_45.5.678.29","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z"},{"key":"2018112909383036000_45.5.678.30","doi-asserted-by":"publisher","DOI":"10.1002\/art.21075"},{"key":"2018112909383036000_45.5.678.31","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0"},{"key":"2018112909383036000_45.5.678.32","first-page":"1272","article-title":"Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course","volume":"30","author":"Liozon","year":"2003","journal-title":"J Rheumatol"},{"key":"2018112909383036000_45.5.678.33","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F"},{"key":"2018112909383036000_45.5.678.34","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu329"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.170455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:28:15Z","timestamp":1543519695000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.170455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,1]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.3899\/jrheum.170455"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.170455","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]}}}